Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.29333
Abstract: Key Points Question What are the relative safety and effectiveness outcomes among patients with nonvalvular atrial fibrillation receiving anticoagulants by CHA2DS2-VASc risk score range, thromboembolic event history, and age group? Findings In this cohort study… read more here.
Keywords: outcomes among; patients nonvalvular; risk; among patients ... See more keywords
Clinical features of ischemic stroke in patients with nonvalvular atrial fibrillation combined with intracranial atherosclerotic stenosis.
Sign Up to like & getrecommendations! Published in 2023 at "Brain and behavior"
DOI: 10.1002/brb3.3036
Abstract: BACKGROUND Nonvalvular atrial fibrillation (NVAF) and intracranial atherosclerotic stenosis (ICAS) are major causes of ischemic stroke. Relatively few studies have focused on the risk factors and clinical features of ischemic stroke caused by NVAF combined… read more here.
Keywords: group; nvaf icas; ischemic stroke; nonvalvular atrial ... See more keywords
Altered profile of circulating microparticles in nonvalvular atrial fibrillation
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Cardiology"
DOI: 10.1002/clc.23158
Abstract: Nonvalvular atrial fibrillation (AF) is the most common cardiac arrhythmia, and it is associated with the prothrombotic state. Circulating microparticles (cMPs) are membrane vesicles that are shed from many cell types in response to cell… read more here.
Keywords: atrial fibrillation; nonvalvular atrial; altered profile; circulating microparticles ... See more keywords
Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF‐Japan): One‐year safety and effectiveness analyses
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Arrhythmia"
DOI: 10.1002/joa3.12332
Abstract: The safety and effectiveness of edoxaban in real‐world clinical settings have not yet been elucidated thoroughly among Japanese patients with nonvalvular atrial fibrillation (NVAF). We report the one‐year interim results of ETNA‐AF‐Japan (Edoxaban Treatment in… read more here.
Keywords: atrial fibrillation; nonvalvular atrial; year; safety effectiveness ... See more keywords
Safety and effectiveness of edoxaban in Japanese patients with nonvalvular atrial fibrillation: Final report of a two‐year postmarketing surveillance study (ETNA‐AF‐Japan)
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Arrhythmia"
DOI: 10.1002/joa3.12520
Abstract: Direct oral anticoagulants (DOACs) are the recommended first‐line therapy for ischemic stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). However, the safety and effectiveness of edoxaban for this indication requires monitoring over the long… read more here.
Keywords: atrial fibrillation; nonvalvular atrial; safety effectiveness; effectiveness edoxaban ... See more keywords
Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease.
Sign Up to like & getrecommendations! Published in 2020 at "American heart journal"
DOI: 10.1016/j.ahj.2020.01.010
Abstract: BACKGROUND There is limited evidence on the effectiveness and safety of direct-acting oral anticoagulants in patients with nonvalvular atrial fibrillation (NVAF) and advanced chronic kidney disease (CKD). This study compared the risks of ischemic stroke/systemic… read more here.
Keywords: atrial fibrillation; nonvalvular atrial; rivaroxaban; warfarin ... See more keywords
Safety and effectiveness of apixaban in comparison to warfarin in patients with nonvalvular atrial fibrillation: a propensity-matched analysis from Japanese administrative claims data
Sign Up to like & getrecommendations! Published in 2018 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2018.1478282
Abstract: Abstract Objective: To investigate the risk of bleeding events and stroke/systemic embolism (SE) among Japanese patients with nonvalvular atrial fibrillation (NVAF), focusing on the initial dosage of apixaban and patient age. Methods: This retrospective cohort… read more here.
Keywords: atrial fibrillation; nonvalvular atrial; warfarin; claims data ... See more keywords
Effectiveness and safety of rivaroxaban in nonvalvular atrial fibrillation: data from a contemporary Spanish registry
Sign Up to like & getrecommendations! Published in 2019 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2019.1600483
Abstract: Abstract Objective: To ascertain the clinical profile, management and rates of thromboembolic and bleeding complications in a contemporary cohort of patients with nonvalvular atrial fibrillation (NVAF) on rivaroxaban treatment, with a particular focus on some… read more here.
Keywords: atrial fibrillation; nonvalvular atrial; rivaroxaban; major bleeding ... See more keywords
Trough Concentration Deficiency of Rivaroxaban in Patients With Nonvalvular Atrial Fibrillation Leading to Thromboembolism Events
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cardiovascular Pharmacology"
DOI: 10.1097/fjc.0000000000001360
Abstract: Abstract: This retrospective study investigated factors influencing the steady-state trough concentrations (Ctrough) of rivaroxaban in patients with nonvalvular atrial fibrillation (NVAF). We retrieved data from patients with NAVF who first started rivaroxaban anticoagulation at the… read more here.
Keywords: rivaroxaban patients; ctrough deficiency; patients nonvalvular; deficiency ... See more keywords
Associations among Plasma Concentrations of Edoxaban and M-4, Prothrombin Time, and the SLCO1B1*15 Haplotype in Patients With Nonvalvular Atrial Fibrillation
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutic Drug Monitoring"
DOI: 10.1097/ftd.0000000000001042
Abstract: Supplemental Digital Content is Available in the Text. Introduction: The authors aimed to examine the impact of single nucleotide polymorphisms in P-glycoprotein, the hepatic uptake transporter organic anion transporter protein 1B1, cytochrome P450 (CYP) 3A5,… read more here.
Keywords: patients nonvalvular; concentrations edoxaban; slco1b1 haplotype; prothrombin time ... See more keywords
Relationship of warfarin versus DOACs with thrombogenic milieu in the left atrium among patients with nonvalvular atrial fibrillation
Sign Up to like & getrecommendations! Published in 2022 at "Echocardiography"
DOI: 10.1111/echo.15319
Abstract: Thrombogenic milieu (TM) within the left atrium plays a pivotal role in the pathogenesis of thromboembolic events, for which anticoagulation treatment is indicated typically on the mandatory basis. Little is known, however, about which regimen… read more here.
Keywords: left atrium; thrombogenic milieu; patients nonvalvular; atrial fibrillation ... See more keywords